...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases
【24h】

Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases

机译:用同时PD-1途径抑制剂和肺癌脑转移患者的肺癌患者立体定向放射术治疗整体存活和型脑疾病控制

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Despite the emerging role of programmed cell death-1 (PD-1) pathway inhibitors for patients with advanced lung cancer, a paucity of data are available on the activity of these agents among patients with brain metastases. We investigated the outcomes of PD-1 pathway inhibitors and stereotactic radiosurgery (SRS) for the treatment of patients with brain metastases from lung cancer.
机译:目的:尽管编程的细胞死亡-1(PD-1)患者为先进的肺癌患者进行了新兴的作用,但患有脑转移患者的这些药剂的活动可获得缺乏数据的缺乏。 我们调查了PD-1途径抑制剂和立体定向放射外科(SRS)的结果,用于治疗肺癌脑转移患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号